Evgen Pharma PLC - ESG Rating & Company Profile powered by AI
This analysis of Evgen Pharma PLC was assembled by All Street Sevva using leading AI. This ESG score covers seventeen UN Sustainable Development Goals including: 'Gender Equality', 'Industry, Innovation & Infrastructure' and 'Partnerships for the Goals'. Alternative corporations in the rating peer group for Evgen Pharma PLC are displayed below.
Evgen Pharma PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 2.7, social score of 4.8 and governance score of 2.7.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1617 | VistaGen Therapeutics Inc | 3.5 | Medium |
| 1617 | Yumanity Therapeutics Inc | 3.5 | Medium |
| 1659 | Evgen Pharma PLC | 3.4 | Medium |
| 1659 | Acceleron Pharma Inc | 3.4 | Medium |
| 1659 | Annexin Pharmaceuticals AB (publ) | 3.4 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Evgen Pharma PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Evgen Pharma PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Evgen Pharma PLC report the average age of the workforce?
Sign up for free to unlockDoes Evgen Pharma PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Evgen Pharma PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Evgen Pharma PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Evgen Pharma PLC offer flexible work?
Sign up for free to unlockDoes Evgen Pharma PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Evgen Pharma PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Evgen Pharma PLC conduct supply chain audits?
Sign up for free to unlockDoes Evgen Pharma PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Evgen Pharma PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Evgen Pharma PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Evgen Pharma PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Evgen Pharma PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Evgen Pharma PLC disclose water use targets?
Sign up for free to unlockDoes Evgen Pharma PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Evgen Pharma PLC have a product recall in the last two years?
Sign up for free to unlockDoes Evgen Pharma PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Evgen Pharma PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Evgen Pharma PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Evgen Pharma PLC disclose parental leave metrics?
Sign up for free to unlockDoes Evgen Pharma PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Evgen Pharma PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Evgen Pharma PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Evgen Pharma PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Evgen Pharma PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Evgen Pharma PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Evgen Pharma PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Evgen Pharma PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Evgen Pharma PLC disclose its waste policy?
Sign up for free to unlockDoes Evgen Pharma PLC report according to TCFD requirements?
Sign up for free to unlockDoes Evgen Pharma PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Evgen Pharma PLC disclose energy use targets?
Sign up for free to unlockDoes Evgen Pharma PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Evgen Pharma PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Evgen Pharma PLC
These potential risks are based on the size, segment and geographies of the company.
Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.